Hormonal contraception
Conditions
Brief summary
Mood and self-perception (Premenstrual symptoms, Positive and negative affect, depression, Anxiety, Gender Role), Cognition (Face recognition, verbal fluency, navigation, working memory), Brain structure, Brain function
Detailed description
sex hormone levels (estradiol, progesterone, allopregnanolone, testosterone dihydrotestosterone, LH, FSH, Prolactin, SHBG), stress hormone levels (cortisol, ACTH), levels of interventional drugs (Ethinylestradiol, Levonorgestrel, Chlormadinonacetate), Genetic variants (repeat polymorphism or SNP) of steroid hormone receptors (AR, ESR1, ESR2, PGR, MR) targeted by the interventional drugs, Genetic variants of genes (repeat polymorphism or SNP) involved in neurotransmitter systems (COMT, MAOA, 5HTT, 5HTR, BDNF) responsive to sex hormones
Interventions
DRUGBILINDA GYNIAL 0
DRUG03 mg/2 mg Filmtabletten
DRUGSelina Gynial 0
DRUG03 mg/0
DRUG15 mg Filmtabletten
Sponsors
Paris Lodron Universitaet Salzburg
Eligibility
Sex/Gender
All
Age
0 Years to 64 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mood and self-perception (Premenstrual symptoms, Positive and negative affect, depression, Anxiety, Gender Role), Cognition (Face recognition, verbal fluency, navigation, working memory), Brain structure, Brain function | — |
Secondary
| Measure | Time frame |
|---|---|
| sex hormone levels (estradiol, progesterone, allopregnanolone, testosterone dihydrotestosterone, LH, FSH, Prolactin, SHBG), stress hormone levels (cortisol, ACTH), levels of interventional drugs (Ethinylestradiol, Levonorgestrel, Chlormadinonacetate), Genetic variants (repeat polymorphism or SNP) of steroid hormone receptors (AR, ESR1, ESR2, PGR, MR) targeted by the interventional drugs, Genetic variants of genes (repeat polymorphism or SNP) involved in neurotransmitter systems (COMT, MAOA, 5HTT, 5HTR, BDNF) responsive to sex hormones | — |
Countries
Austria
Outcome results
None listed